Skip to main content
$8.40 -$0.11 (-1.3%)

04:30 PM EDT on 09/22/20

Fluidigm Corp. (NASDAQ:FLDM)

CAPS Rating: No stars

Current Price $8.40 Mkt Cap $606.9M
Open $8.38 P/E Ratio 0.00
Prev. Close $8.40 Div. (Yield) $0.00 (0.0%)
Daily Range $8.17 - $8.84 Volume 1,044,105
52-Wk Range $1.17 - $12.45 Avg. Daily Vol. 9,645,910

Caps

How do you think NASDAQ:FLDM will perform against the market?

Add Stock to CAPS Watchlist

All Players

16 Outperform
11 Underperform
 

All-Star Players

2 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:FLDM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Chinoster7u (< 20)
Submitted September 25, 2012

They are creating the new wave of medical diagnostic machines. The tiny scale of their devices will increase use in space, the battlefield, 3rd world countries, scientific research and even robotics and computing. Besides increasing use it will… More

4sigma (26.84)
Submitted February 14, 2012

Marketing to a very select audience. Agriculture biology? Only 300 systems sold and 10 mil dollars in REVENUE each year. This company makes very little money with lots of expenses.

NASDAQ:FLDM VS S&P 500 (SPY)

Fools bullish on NASDAQ:FLDM are also bullish on:

Fools bearish on NASDAQ:FLDM are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about FLDM.

Recs

0
Member Avatar Jaaaaason (< 20) Submitted: 9/4/2020 12:14:47 PM : Outperform Start Price: $5.67 NASDAQ:FLDM Score: +50.49

Game changing technology with the ability to analyze individual cells with multiple markers.

Recs

0
Member Avatar SeedTownBrothers (53.07) Submitted: 5/12/2017 1:57:14 PM : Outperform Start Price: $5.75 NASDAQ:FLDM Score: +7.87

• The turnaround for this San Francisco company will likely take place in the 2. half of 2017 - with a Mkt.Cap of 200m$ & rev. of 100m$ a year in a high-margin business, there's a lot of upside potential.

• Fluidigm is maturing - financially disciplined, refocused attention on core rev. for the future & currently streamlining internal communications, team-structures & work-flow.

• Early adopters of "CyTOF" -like univ. researchers- have leveraged this technology in single cell analysis to obtain results previously not possible, & CyTOF is seeing more-&-m. positive attention & interest in the life-sciences (just google "CyTOF").

• CyTOF was first developed between the Univ. of Toronto & DVS Sciences Inc. which Fluidigm acquired in 2014 & further developed (https://en.m.wikipedia.org/wiki/Mass_cytometry).

• May 2017 conf. call (https://seekingalpha.com/article/4069444-fluidigm-corps-fldm-ceo-stephen-linthwaite-q1-2017-results-earnings-call-transcript).

• Institutional ownership is at ~100% (http://www.nasdaq.com/symbol/fldm/institutional-holdings)
... for a company this small, there is obviously significant risk & you should do your own research & only invest in what you understand... with that being said - if you were ever looking for an "early company" before they were discovered & their potential realized by the broader market (and not just their customers), then you should take a look at Fluidigm.

• Insider shares traded have also been relatively healthy
(http://www.nasdaq.com/symbol/fldm/insider-trades)

• Universities & research-institutions adopting Fluidigm's tech. are also likely to invest in the company.

• But you should only invest in something you understand - Googling "Fluidigm", "CyTOF" or "Mass Cytometry" is a good place to start...

Recs

0
Member Avatar dalepasta (< 20) Submitted: 2/28/2016 1:16:53 PM : Outperform Start Price: $6.64 NASDAQ:FLDM Score: -42.78

Little understanding of the bio tools space undervalues this stock.

Leaderboard

Find the members with the highest scoring picks in FLDM.

Score Leader

NextGenStock

NextGenStock (39.71) Score: +218.54

The Score Leader is the player with the highest score across all their picks in FLDM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
NextGenStock 39.71 11/6/2019 Outperform 5Y $2.58 +226.21% +7.68% +218.54 0 Comment
4sigma 26.84 2/14/2012 Underperform 5Y $14.54 -42.23% +144.67% +186.90 3 Comments
mountaincouger 28.39 7/25/2012 Underperform 5Y $12.95 -35.14% +145.98% +181.11 0 Comment
Squeege1981 61.96 12/24/2012 Underperform 3Y $14.44 -41.83% +131.82% +173.65 0 Comment
CAPSTech 48.25 11/1/2013 Underperform 3M $31.39 -73.24% +88.12% +161.36 0 Comment
eagles777 67.16 5/4/2020 5/28/2020 Outperform NS $3.04 +176.32% +17.66% +158.65 0 Comment
wahodges 88.52 5/19/2014 Underperform 5Y $27.08 -68.98% +75.98% +144.96 0 Comment
andrewdski 89.94 1/20/2015 Underperform 3M $36.47 -76.96% +64.34% +141.30 0 Comment
Lmar 92.76 8/14/2015 Underperform 5Y $12.65 -33.60% +58.47% +92.07 0 Comment
Jaaaaason < 20 9/4/2020 Outperform 5Y $5.67 +48.15% -2.34% +50.49 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for FLDM.